Free Trial
ASX:RAP

ResApp Health (RAP) Stock Price, News & Analysis

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)
Free RAP Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
932,978 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About ResApp Health

ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company offers ResAppDx, a smartphone-based acute respiratory disease diagnostic test for use in telehealth, emergency department, and primary care markets; and SleepCheck, a smartphone application that allows consumers to self-assess the risk of sleep apnoea. Its technology uses sound to diagnose respiratory diseases, including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease, and asthma. ResApp Health Limited has a joint development and pilot agreement with Medgate AG to integrate and test smartphone-based acute respiratory diagnostic test. The company was formerly known as Narhex Life Sciences Limited. ResApp Health Limited was incorporated in 2000 and is headquartered in Brisbane, Australia.

RAP Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive RAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ResApp Health and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
ASX:RAP
CUSIP
N/A
CIK
N/A
Web
www.resapphealth.com.au
Phone
61 7 3724 0035
Fax
N/A
Employees
500
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
5.64
Current Ratio
0.86
Quick Ratio
0.82

Sales & Book Value

Annual Sales
$3.81 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
28.33
Book Value
A$0.00 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
859,697,024
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Anthony Keating
    CEO, MD & Director
  • Mr. Brian Leedman B.Econ.
    BECON, M.B.A., Exec. Director of Corp. Affairs & Exec. Director
  • Al Rey Lunar CPA
    VP of Fin.
  • Mr. Scott Savage
    VP of Technology & Product
  • Ms. Nicki Farley (Age 46)
    Company Sec.
  • Dr. Clas Källander
    Founder and Director of R&D of Cavidi AB
  • Mr. Mike Connell
    VP of Commercial
  • Dr. Paul Porter MBBS FRACP
    Scientific Advisor

Key Competitors

View All Competitors

This page (ASX:RAP) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
[Shocking] Elon Musk’s Plan To End Banks
Crypto 101 Media
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
The #1 Crypto for 2024
InvestorPlace